
Genmab to buy Dutch cancer drugmaker Merus for $8 billion
OSLO (Reuters) -Denmark's Genmab has agreed to acquire Merus NV, a Nasdaq-listed Dutch biotech firm...
29th September, 2025

OSLO (Reuters) -Denmark's Genmab has agreed to acquire Merus NV, a Nasdaq-listed Dutch biotech firm...
29th September, 2025
(Reuters) -The UK government is set to offer to pay more for certain medicines to protect pharmaceut...
26th September, 2025
By Ahmed Aboulenein and Robin Respaut WASHINGTON (Reuters) -The U.S. National Institutes of Health g...
25th September, 2025

DUBAI (Reuters) -A woman jailed in Iran over accusations she had links to a banned political group d...
25th September, 2025
(Reuters) -Philips is actively engaged with policymakers in Washington about investigations into U.S...
25th September, 2025
(Reuters) -European shares eased on Thursday as losses in healthcare and industrials weighed early o...
25th September, 2025

By Gabriel Stargardter PARIS (Reuters) -Fabrice Lehmann caught sight of his target as he left his su...
25th September, 2025
By Diana Novak Jones (Reuters) -Families appealing the dismissal of their lawsuits alleging that Ken...
25th September, 2025
(Reuters) -A Paris court on Wednesday ordered Sanofi and its Winthrop unit to pay 150.7 million euro...
24th September, 2025
By Muvija M LONDON (Reuters) -Eli Lilly Chief Executive Dave Ricks said Britain was "probably the wo...
24th September, 2025
By Emma Rumney and Jennifer Rigby LONDON (Reuters) -The Belgian beer industry, Mexico's tequila make...
24th September, 2025
(Reuters) -Johnson & Johnson will withdraw a device to treat acid reflux disease from markets outsid...
23rd September, 2025